2025 annual financial data
Travere Therapeutics 2025 Revenue growth
Direct answer
Revenue growth was 110.45%.
Operating income was -62,824,000 USD and net income was -25,546,000 USD.
Operating cash flow was 37,784,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 490,728,000 USD
- Operating income
- -62,824,000 USD
- Net income
- -25,546,000 USD
- Operating cash flow
- 37,784,000 USD